Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q9GZN0
UPID:
GPR88_HUMAN
Alternative names:
Striatum-specific G-protein coupled receptor
Alternative UPACC:
Q9GZN0; Q29S24; Q6VN48
Background:
The Probable G-protein coupled receptor 88, also known as Striatum-specific G-protein coupled receptor, plays a pivotal role in coordinating motor activities, spatial learning, and emotional responses. Its involvement in cognitive and motor functions underscores its significance in the central nervous system.
Therapeutic significance:
Linked to Chorea, childhood-onset, with psychomotor retardation, understanding the role of Probable G-protein coupled receptor 88 could open doors to potential therapeutic strategies.